Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer?

[1]  A. Wagner,et al.  Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. , 2015, Gastroenterology.

[2]  Nazneen Rahman,et al.  Gene-panel sequencing and the prediction of breast-cancer risk. , 2015, The New England journal of medicine.

[3]  R. van Hillegersberg,et al.  Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers , 2015, Journal of Medical Genetics.

[4]  B. Fernandez,et al.  Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. , 2015, JAMA oncology.

[5]  L. Dossus,et al.  Lobular breast cancer: incidence and genetic and non-genetic risk factors , 2015, Breast Cancer Research.

[6]  R. Seruca,et al.  Familial gastric cancer: genetic susceptibility, pathology, and implications for management. , 2015, The Lancet. Oncology.

[7]  M. Simpson,et al.  Germline CDH1 mutations in bilateral lobular carcinoma in situ , 2013, British Journal of Cancer.

[8]  A. Sézeur,et al.  CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study , 2013, Journal of Medical Genetics.

[9]  I. Choi,et al.  Association of family history with cancer recurrence and survival in patients with gastric cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  W. Foulkes,et al.  Inherited Mutations in Breast Cancer Genes—Risk and Response , 2011, Journal of Mammary Gland Biology and Neoplasia.

[11]  S. Domchek,et al.  Clinical Management of Hereditary Breast Cancer Syndromes , 2011, Journal of Mammary Gland Biology and Neoplasia.

[12]  O. Olopade,et al.  Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers , 2010, Journal of Medical Genetics.

[13]  C. Caldas,et al.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research , 2010, Journal of Medical Genetics.

[14]  Karla Kerlikowske,et al.  Risk Factors for Ductal, Lobular, and Mixed Ductal-Lobular Breast Cancer in a Screening Population , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[15]  J. Sandbank,et al.  Factors affecting rise in the incidence of infiltrating lobular carcinoma of the breast. , 2010, The Israel Medical Association journal : IMAJ.

[16]  V. Beral,et al.  Family history and breast cancer tumour characteristics in screened women , 2008, International journal of cancer.

[17]  R. Gelber,et al.  Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  P. Lønning,et al.  Breast cancer prognostication and prediction in the postgenomic era. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  P. Miron,et al.  Germline E-cadherin mutations in familial lobular breast cancer , 2007, Journal of Medical Genetics.

[20]  B. Fernandez,et al.  Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. , 2007, JAMA.

[21]  K. Hemminki,et al.  Familial risk for gastric carcinoma: an updated study from Sweden , 2007, British Journal of Cancer.

[22]  M. García-Closas,et al.  Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[23]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[24]  B. Strom,et al.  Relationship between Established Breast Cancer Risk Factors and Risk of Seven Different Histologic Types of Invasive Breast Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[25]  I. Siccama,et al.  Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data , 2006, Journal of Clinical Pathology.

[26]  N. Camp,et al.  Lobular breast cancer: Excess familiality observed in the Utah Population Database , 2005, International journal of cancer.

[27]  A. Ashworth,et al.  Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity , 2005, The Journal of pathology.

[28]  W. Foulkes,et al.  Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria , 2004, Journal of Medical Genetics.

[29]  David Botstein,et al.  Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. , 2004, Molecular biology of the cell.

[30]  R. Elledge,et al.  Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome , 2004, Breast Cancer Research.

[31]  F. Graziano,et al.  The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  J. Herman,et al.  Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: Relationships with abnormal E‐cadherin and catenin expression and microsatellite instability , 2003, International journal of cancer.

[33]  B. Anderson,et al.  Trends in incidence rates of invasive lobular and ductal breast carcinoma. , 2003, JAMA.

[34]  K. Hemminki,et al.  Familial breast carcinoma risks by morphology , 2002, Cancer.

[35]  H. Grönberg,et al.  Germline mutations in E‐cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer , 2002, International journal of cancer.

[36]  A. Cleton-Jansen.  E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? , 2001, Breast Cancer Research.

[37]  R. Goldbohm,et al.  Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease , 2001, The Lancet.

[38]  D. Bowen,et al.  Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[39]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[40]  M. Stratton,et al.  The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[41]  H. Höfler,et al.  Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. , 1999, The American journal of pathology.

[42]  J. V. van Sandick,et al.  Prognostic Value of Laurén Classification and c-erbB-2 Oncogene Overexpression in Adenocarcinoma of the Esophagus and Gastroesophageal Junction , 1999, Annals of Surgical Oncology.

[43]  Anthony E. Reeve,et al.  E-cadherin germline mutations in familial gastric cancer , 1998, Nature.

[44]  M. Slattery,et al.  Comparison of self-reported and database-linked family history of cancer data in a case-control study. , 1997, American journal of epidemiology.

[45]  J. Manson,et al.  Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. , 1993, JAMA.

[46]  D. Hunter,et al.  Molecular Epidemiology of Cancer , 2005, CA: a cancer journal for clinicians.

[47]  K. Hemminki,et al.  A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA 1 and BRCA 2 mutations , 2005 .